NEW YORK – T2 Biosystems said on Wednesday that it has received the CE-IVD mark for its T2Resistance Panel to detect genetic signatures of drug-resistant bacteria.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.